JCIC Asset Management Inc. Acquires 3,514 Shares of UnitedHealth Group Inc (UNH)

Share on StockTwits

JCIC Asset Management Inc. increased its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 33.0% in the 3rd quarter, Holdings Channel reports. The firm owned 14,149 shares of the healthcare conglomerate’s stock after acquiring an additional 3,514 shares during the quarter. JCIC Asset Management Inc.’s holdings in UnitedHealth Group were worth $3,764,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also modified their holdings of the company. Welch Group LLC acquired a new stake in UnitedHealth Group during the second quarter valued at $106,000. Blue Chip Partners Inc. acquired a new stake in UnitedHealth Group during the second quarter valued at $107,000. Northwest Wealth Management LLC acquired a new stake in UnitedHealth Group during the second quarter valued at $117,000. Fort L.P. acquired a new stake in shares of UnitedHealth Group in the second quarter valued at about $119,000. Finally, Stelac Advisory Services LLC acquired a new stake in shares of UnitedHealth Group in the first quarter valued at about $163,000. 85.35% of the stock is owned by hedge funds and other institutional investors.

UNH has been the topic of several research analyst reports. Jefferies Financial Group lifted their target price on shares of UnitedHealth Group from $270.00 to $311.00 and gave the company a “buy” rating in a research report on Wednesday, October 3rd. Morgan Stanley lifted their target price on shares of UnitedHealth Group from $278.00 to $305.00 and gave the company an “overweight” rating in a research report on Wednesday, September 5th. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 18th. ValuEngine upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Tuesday, October 2nd. Finally, Cantor Fitzgerald reiterated a “buy” rating and issued a $300.00 target price on shares of UnitedHealth Group in a research report on Thursday, July 5th. One equities research analyst has rated the stock with a hold rating, twenty-two have issued a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $278.61.

In related news, CEO Steven H. Nelson sold 8,142 shares of the business’s stock in a transaction dated Thursday, September 13th. The shares were sold at an average price of $265.00, for a total transaction of $2,157,630.00. Following the transaction, the chief executive officer now directly owns 22,496 shares in the company, valued at $5,961,440. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP D Ellen Wilson sold 15,393 shares of the business’s stock in a transaction dated Friday, August 24th. The stock was sold at an average price of $264.29, for a total transaction of $4,068,215.97. Following the transaction, the executive vice president now owns 66,402 shares in the company, valued at $17,549,384.58. The disclosure for this sale can be found here. Insiders have sold 94,745 shares of company stock worth $24,995,290 over the last 90 days. 0.87% of the stock is currently owned by company insiders.

UNH opened at $259.61 on Friday. The stock has a market cap of $256.06 billion, a P/E ratio of 25.78, a price-to-earnings-growth ratio of 1.58 and a beta of 0.73. UnitedHealth Group Inc has a twelve month low of $186.00 and a twelve month high of $272.07. The company has a current ratio of 0.75, a quick ratio of 0.75 and a debt-to-equity ratio of 0.63.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 17th. The healthcare conglomerate reported $3.14 earnings per share for the quarter, topping analysts’ consensus estimates of $3.04 by $0.10. The firm had revenue of $56.09 billion for the quarter, compared to analyst estimates of $56.10 billion. UnitedHealth Group had a net margin of 5.55% and a return on equity of 22.79%. UnitedHealth Group’s quarterly revenue was up 12.1% on a year-over-year basis. During the same period in the previous year, the business posted $2.46 earnings per share. Equities analysts predict that UnitedHealth Group Inc will post 12.72 EPS for the current year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 18th. Investors of record on Friday, September 7th were given a dividend of $0.90 per share. The ex-dividend date was Thursday, September 6th. This represents a $3.60 dividend on an annualized basis and a yield of 1.39%. UnitedHealth Group’s payout ratio is presently 35.75%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: Google Finance Portfolio

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.